AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 283: E1151-E1158, 2002; doi:10.1152/ajpendo.00223.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donmoyer, C. M.
Right arrow Articles by McGuinness, O. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Donmoyer, C. M.
Right arrow Articles by McGuinness, O. P.
Vol. 283, Issue 6, E1151-E1158, December 2002

Impact of chronic fructose infusion on hepatic metabolism during TPN administration

Christine M. Donmoyer, D. Brooks Lacy, Yiqun Zhang, Sheng-Song Chen, and Owen P. McGuinness

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232-0615

During chronic total parenteral nutrition (TPN), net hepatic glucose uptake (NHGU) is markedly elevated. However, NHGU is reduced by the presence of an infection. We recently demonstrated that a small, acute (3-h) intraportal fructose infusion can correct the infection-induced impairment in NHGU. The aim of this study was to determine whether the addition of fructose to the TPN persistently enhances NHGU in the presence of an infection. TPN was infused continuously into the inferior vena cava of chronically catheterized dogs for 5 days. On day 3, a bacterial clot was implanted in the peritoneal cavity, and either saline (CON, n = 5) or fructose (+FRUC, 1.0 mg · kg-1 · min-1, n = 6) infusion was included with the TPN. Forty-two hours after the infection was induced, hepatic glucose metabolism was assessed in conscious dogs with arteriovenous and tracer methods. Arterial plasma glucose concentration was lower with chronic fructose infusion (120 ± 4 vs. 131 ± 3 mg/dl, +FRUC vs. CON, P < 0.05); however, NHGU was not enhanced (2.2 ± 0.5 vs. 2.8 ± 0.4 mg · kg-1 · min-1). Acute removal of the fructose infusion dramatically decreased NHGU (2.2 ± 0.5 to -0.2 ± 0.5 mg · kg-1 · min-1), and net hepatic lactate release also fell (1.6 ± 0.3 to 0.5 ± 0.3 mg · kg-1 · min-1). This led to an increase in the arterial plasma glucose (Delta 13 ± 3 mg/dl, P < 0.05) and insulin (Delta 5 ± 2 µU/ml) concentrations and to a decrease in glucagon (Delta -11 ± 3 pg/ml) concentration. In conclusion, the addition of chronic fructose infusion to TPN during infection does not lead to a persistent augmentation of NHGU.

liver; lactate; dog


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-S. Chen, Y. Zhang, T. S. Santomango, P. E. Williams, D. B. Lacy, and O. P. McGuinness
Glucagon chronically impairs hepatic and muscle glucose disposal
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E928 - E935.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online